HealthStream Posts Record Q2 Revenue and Lifts Full-Year Outlook
HSTM sits 45% above its 52-week low of $19.5.
Summary
HealthStream posted record Q2 2026 revenue of $83.7M (+12.5% YoY) and raised full-year guidance, demonstrating strong business momentum despite a recent cybersecurity incident.
Key Events · Earnings and Guidance · HSTM
-
Record Q2 Revenue
Revenue reached $83.7 million, a 12.5% increase from $74.4 million in Q2 2025, driven by subscription growth and acquisitions.
-
Profitability Surge
Operating income rose 41.4% to $8.3 million; net income grew 23.8% to $6.7 million, or $0.23 per diluted share.
-
Raised Full-Year Guidance
Revenue guidance lifted to $327–332 million (from $323–330 million); Adjusted EBITDA now seen at $74–78 million (from $73–77 million).
-
Dividend Declared
Board declared a quarterly cash dividend of $0.035 per share, payable August 28 to shareholders of record August 17.
Analysis · HSTM · Technology
Coming just days after a disclosed cybersecurity breach, HealthStream's record quarterly revenue of $83.7 million—up 12.5% year-over-year—and a 41.4% surge in operating income provide a powerful counterbalance for investors gauging the company's resilience. The raised full-year revenue and Adjusted EBITDA guidance further signal management's confidence in sustained demand for its clinical workforce solutions.
At the time of this filing, HSTM was trading at $28.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $827.7M. The 52-week trading range was $19.50 to $30.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.